785
Views
36
CrossRef citations to date
0
Altmetric
Reviews

The management of neuroendocrine tumours: A nutritional viewpoint

ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon & show all

References

  • American Diabetes Association. 2017. 4. Lifestyle Management. Diabetes Care 40:S33–S43. https://doi.org/10.2337/dc17-S007.
  • Anthony, L. B. 2010. Diarrhoea, constipation, and obstruction in cancer management,” in The MASCC Textbook of Cancer Supportive Care and Survivorship ed. N. Ian Olver, ed. (Berlin: Springer) 249–260.
  • Arnold, M., N. Pandeya, G. Byrnes, A. G. Renehan, G. A. Stevens, M. Ezzati, J. Ferlay, J. J. Miranda, I. Romieu, R. Dikshit, D. Forman, and I. Soerjomataram 2015. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 16:36–46. https://doi.org/10.1016/S1470-2045(14)71123-4.
  • BAPEN. Introducing “MUST”. 2015. http://www.bapen.org.uk/screening-for-malnutrition/must/introducing-must (Accessed 09 Aug 2017).
  • Barbosa-Silva, M. C., A. J. Barros, J. Wang, S. B. Heymsfield, and R. N. Jr Pierson. 2005. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 82:49–52.
  • Barrea, L., G. Muscogiuri, P. E. Macchia, C. Di Somma, A. Falco, M. C. Savanelli, A. Colao, and S. Savastano 2017. Mediterranean Diet and Phase Angle in a Sample of Adult Population: Results of a Pilot Study. Nutrients. 9. pii: E151.
  • Blanchard, C. M., K. S. Courneya, and K. Stein 2008. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol 26:2198–2204. https://doi.org/10.1200/JCO.2007.14.6217.
  • Baur, B., M. Oroszlan, O. Hess, T. Carrel, and P. Mohacsi 2011. Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis. Transplant Proc 43:1853–1861. https://doi.org/10.1016/j.transproceed.2011.01.174.
  • Bosman, F. T., and World Health Organization, International Agency for Research on Cancer. 2010. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer.
  • Bosy-Westphal, A., C. A. Booke, T. Blöcker, E. Kossel, K. Goele, W. Later, B. Hitze, M. Heller, C. C. Glüer, and M. J. Müller 2010. Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J Nutr 140:954–961. https://doi.org/10.3945/jn.109.118737.
  • Boutzios, G., and G. Kaltsas 2015. Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms. Front Horm Res 44:40–57. doi: 10.1159/000382053. https://doi.org/10.1159/000382053.
  • Brattström, C., H. Wilczek, G. Tydén, Y. Böttiger, J. Säwe, and C. G. Groth 1998. Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin). Transplantation 65:1272–1274. https://doi.org/10.1097/00007890-199805150-00023.
  • Byers, T., and R. L. Sedjo 2015. Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms. Endocr Relat Cancer 22:R125–134. https://doi.org/10.1530/ERC-14-0580.
  • Chung, C. 2016. Management of neuroendocrine tumours. Am J Health-Syst Pharm 73:1729–1744. https://doi.org/10.2146/ajhp150373.
  • Cryer, P. E., L. Axelrod, A. B. Grossman, S. R. Heller, V. M. Montori, E. R. Seaquist, and F. J. Service, Endocrine Society. 2009. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94:709–728. doi: 10.1210/jc.2008-1410. https://doi.org/10.1210/jc.2008-1410.
  • Dasari, A., C. Shen, D. Halperin, B. Zhao, S. Zhou, Y. Xu, T. Shih, and J. C. Yao 2017 Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumours in the United States. JAMA Oncol doi: 10.1001/jamaoncol.2017.0589. https://doi.org/10.1001/jamaoncol.2017.0589.
  • Davies, A. H., G. Larsson, J. Ardill, E. Friend, L. Jones, M. Falconi, R. Bettini, M. Koller, O. Sezer, C. Fleissner, B. Taal, J. M. Blazeby, and J. K. Ramage, EORTC Quality of Life Group 2006. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours. Eur J Cancer 42:477–484. https://doi.org/10.1016/j.ejca.2005.10.025.
  • de Herder, W. W., B. Niederle, J. Y. Scoazec, S. Pauwels, G. Kloppel, M. Falconi, D. J. Kwekkeboom, K. Oberg, B. Wiedenmann, G. Rindi, D. O'Toole, and D. Ferone, Frascati Consensus Conference; European Neuroendocrine Tumour Society. 2006. Well-differentiated pancreatic tumour/carcinoma: insulinoma. Neuroendocrinology 84:183–188. https://doi.org/10.1159/000098010.
  • De Lorenzo, A., A. Bianchi, P. Maroni, A. Iannarelli, N. Di Daniele, L. Iacopino, and L. Di Renzo 2013. Adiposity rather than BMI determines metabolic risk. Int J Cardiol. 166:111–117. https://doi.org/10.1016/j.ijcard.2011.10.006.
  • dePeyster, F. A., and R. K. Gilchrist 1954. Clinical response of spontaneous hypoglycaemia to dietary and drug therapy. J Am Med Assoc 155:884–889. https://doi.org/10.1001/jama.1954.03690280008002.
  • Detsky, A. S., J. P. Baker, R. A. Mendelson, S. L. Wolman, D. E. Wesson, and K. N. Jeejeebhoy 1984. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr 8:153–159. https://doi.org/10.1177/0148607184008002153.
  • Dietary Guidelines for Americans 2005. (2005). Washington: US Government Printing Office: Dietary Guidelines Advisory Committee; US Department of Health and Human Services, US Department of Agriculture.
  • Ekeblad, S., B. Skogseid, K. Dunder, K. Oberg, and B. Eriksson 2008. Prognostic factors and survival in 324 patients with pancreatic endocrine tumour treated at a single institution. Clin Cancer Res 14:7798–7803. doi:10.1158/1078-0432.CCR-08-0734. https://doi.org/10.1158/1078-0432.CCR-08-0734.
  • Esposito, K., M. I. Maiorino, M. Ciotola, C. Di Palo, P. Scognamiglio, M. Gicchino, M. Petrizzo, F. Saccomanno, F. Beneduce, A. Ceriello, and D. Giugliano 2009. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 151:306–314. https://doi.org/10.7326/0003-4819-151-5-200909010-00004.
  • Evert, A. B., J. L. Boucher, M. Cypress, S. A. Dunbar, M. J. Franz, E. J. Mayer-Davis, J. J. Neumiller, R. Nwankwo, C. L. Verdi, P. Urbanski, and W. S. Jr Yancy. 2014. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 37:S120–S143. https://doi.org/10.2337/dc14-S120.
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 285:2486–2497.
  • Faggiano, A., P. Ferolla, F. Grimaldi, D. Campana, M. Manzoni, M. V. Davì, A. Bianchi, R. Valcavi, E. Papini, D. Giuffrida, D. Ferone, G. Fanciulli, G. Arnaldi, G. M. Franchi, G. Francia, G. Fasola, L. Crinò, A. Pontecorvi, P. Tomassetti, and A. Colao 2012. Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumours. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest 35:817–823. doi: 10.3275/8102.
  • Frisancho, A. R. 1981. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 34:2540–2545.
  • Gallo, M., P. Malandrino, G. Fanciulli, F. Rota, A. Faggiano, and A. Colao, on behalf of NIKE Group. 2017. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives. J Cancer Res Clin Oncol 143:1209–1224. doi: 10.1007/s00432-017-2407-5. https://doi.org/10.1007/s00432-017-2407-5.
  • Go, V. L., P. Srihari, and L. A. Kamerman Burns 2010. Nutrition and gastroenteropancreatic neuroendocrine tumours. Endocrinol Metab Clin North Am 39:827–837. https://doi.org/10.1016/j.ecl.2010.08.003.
  • Grundmann, O., S. L. Yoon, and J. J. Williams 2015. The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients–a comprehensive review. Eur J Clin Nutr 69:1290–1297. https://doi.org/10.1038/ejcn.2015.126.
  • Gupta, D., and C. G. Lis 2010. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69. https://doi.org/10.1186/1475-2891-9-69.
  • Gut, P., J. Waligórska-Stachura, A. Czarnywojtek, N. Sawicka-Gutaj, M. Bączyk, K. Ziemnicka, J. Fischbach, K. Woliński, J. Kaznowski, E. Wrotkowska, and M. Ruchała. 2017. Management of the hormonal syndrome of neuroendocrine tumours. Arch Med Sci 13:515–524. doi: 10.5114/aoms.2016.60311 https://doi.org/10.5114/aoms.2016.60311.
  • Halfdanarson, T. R., K. G. Rabe, J. Rubin, and G. M. Petersen 2008. Pancreatic neuroendocrine tumours (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol 19:1727–1733. doi: 10.1093/annonc/mdn351.
  • Hannah-Shmouni, F., C. A. Stratakis, and C. A. Koch 2016. Flushing in (neuro)endocrinology. Rev Endocr Metab Disord 17:373–380.
  • Haverkort, E. B., P. L. Reijven, J. M. Binnekade, M. A. de van der Schueren, C. P. Earthman, D. J. Gouma, and R. J. de Haan 2015. Bioelectrical impedance analysis to estimate body composition in surgical and oncological patients: a systematic review. Eur J Clin Nutr 69:3–13.
  • Hutton, J. L., L. Martin, C. J. Field, W. V. Wismer, E. D. Bruera, S. M. Watanabe, and V. E. Baracos 2006. Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy. Am J Clin Nutr 84:1163–1170.
  • Jones, L. W., and W. Demark-Wahnefried 2006. Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 7:1017–1026.
  • Kaltenbach, T., S. Crockett, and L. B. Gerson 2006. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 166:965–971.
  • Kaltsas, G. A., G. M. Besser, and A. B. Grossman 2004. The diagnosis and medical management of advanced neuroendocrine tumours. Endocr Rev 25:458–511.
  • Kandaswamy, L., R. Raghavan, and J. M. Pappachan 2016. Spontaneous hypoglycaemia: diagnostic evaluation and management. Endocrine 53:47–57. doi: 10.1007/s12020-016-0902-0.
  • Kondrup, J., H. H. Rasmussen, O. Hamberg, and Z. Stanga, Ad Hoc ESPEN Working Group 2003. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22:321–336.
  • Kulke, M. H., D. Hörsch, M. E. Caplin, L. B. Anthony, E. Bergsland, K. Öberg, S. Welin, R. R. Warner, C. Lombard-Bohas, P. L. Kunz, E. Grande, J. W. Valle, D. Fleming, P. Lapuerta, P. Banks, S. Jackson, B. Zambrowicz, A. T. Sands, and M. Pavel 2017. Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome. J Clin Oncol 35:14–23.
  • Kyle, U. G., M. Pirlich, T. Schuetz, H. Lochs, and C. Pichard 2004. Is nutritional depletion by Nutritional Risk Index associated with increased length of hospital stay? A population-based study. J Parenter Enteral Nutr 28:99–104.
  • Kyrgiou, M., I. Kalliala, G. Markozannes, M. J. Gunter, E. Paraskevaidis, H. Gabra, P. Martin-Hirsch, and K. K. Tsilidis 2017. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356:j477.
  • Lorber, M. I., S. Mulgaonkar, K. M. Butt, E. Elkhammas, R. Mendez, P. R. Rajagopalan, B. Kahan, H. Sollinger, Y. Li, N. Cretin, and H. Tedesco, B251 Study Group 2005. Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study. Transplantation 80:244–252.
  • Leoncini, E., G. Carioli, C. La Vecchia, S. Boccia, and G. Rindi 2016. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol 27:68–81.
  • Leoncini, E., P. Boffetta, M. Shafir, K. Aleksovska, S. Boccia, and G. Rindi 2017. Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms. Endocrine doi: 10.1007/s12020-017-1273-x.
  • Maasberg, S., B. Knappe-Drzikova, D. Vonderbeck, H. Jann, K. H. Weylandt, C. Grieser, A. Pascher, J. C. Schefold, M. Pavel, B. Wiedenmann, A. Sturm, and U. F. Pape 2017. Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia. Neuroendocrinology 104:11–25.
  • Mamikuniam, G., A. I. Vinik, T. M. O'Dorisio, E. A. Woltering, and V. L. W. Go 2009. Neuroendocrine tumours, a comprehensive guide to diagnoses and management. 4th edition. Los Angeles (CA): Interscience Institute.
  • Marciello, F., O. Mercier, P. Ferolla, J. Y. Scoazec, P. L. Filosso, A. Chapelier, G. Guggino, R. Monaco, F. Grimaldi, S. Pizzolitto, J. Guygay, B. R. de Latour, D. Giuffrida, E. Longchampt, V. T. de Montpreville, É. Fadel, A. Colao, D. Planchard, M. Papotti, A. Faggiano, and E. Baudin 2017. Natural History of Localized and Locally Advanced Lung atypical Carcinoid after Complete Resection: A Joined French-ITALIAN Multicentric Retrospective Study. Neuroendocrinology Aug 17. doi: 10.1159/000480015. [Epub ahead of print].
  • Marrache, F., M. P. Vullierme, C. Roy, Y. El Assoued, A. Couvelard, D. O'Toole, E. Mitry, O. Hentic, P. Hammel, P. Lévy, P. Ravaud, P. Rougier, and P. Ruszniewski 2007. Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. Br J Cancer 96:49–55.
  • Martínez-González, M. A., A. García-Arellano, E. Toledo, J. Salas-Salvadó, P. Buil-Cosiales, D. Corella, M. I. Covas, H. Schröder, F. Arós, E. Fiol, M. Ruiz-Gutiérrez, V. Gómez-Gracia, J. Lapetra, R. M. Lamuela-Raventos, L. Serra-Majem, X. Pintó, M. A. Muñoz, J. Wärnberg, E. Ros, and R. Estruch, PREDIMED Study Investigators. 2012. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial. PLoS ONE e43134.
  • Minuto, F., D. Ferone, M. Boschetti, M. Albertelli, and F. Gatto 2014. Diabetes Secondary to Neuroendocrine Gastroenteropancreatic Tumours. In: Diabetes Secondary to Endocrine and Pancreatic Disorders, 22: pp. 64–76. E., Ghigo and M., Porta, D. Front, ed., Basel: Karger.
  • Modlin, I. M., K. Oberg, D. C. Chung, R. T. Jensen, W. W. de Herder, R. V. Thakker, M. Caplin, G. Delle Fave, G. A. Kaltsas, E. P. Krenning, S. F. Moss, O. Nilsson, G. Rindi, R. Salazar, P. Ruszniewski, and A. Sundin 2008. The current status of gastroenteropancreatic neuroendocrine tumours. Lancet Oncology 9:61–72.
  • Murphy, R. A., M. Mourtzakis, Q. S. Chu, T. Reiman, and V. C. Mazurak 2010. Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J Nutr 140:1602–1606.
  • Namiki, M., S. Ueno, Y. Kitagawa, H. Konaka, A. Mizokami, E. Koh, and T. Fukagai 2007. Hormonal therapy. Int J Clin Oncol 12:427–432.
  • National Collaborating Centre for Acute Care. 2006. Nutrition support in adults Oral nutrition support, enteral tube feeding and parenteral nutrition. National Collaborating Centre for Acute Care, London. http://www.rcseng.ac.uk. Accessed August 9, 2017.
  • Ness-Jensen, E., K. Hveem, H. El-Serag, and J. Lagergren 2016. Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol 14:175–182.
  • Norman, K., C. Pichard, H. Lochs, and M. Pirlich 2008. Prognostic impact of disease-related malnutrition. Clin Nutr 27:5–15.
  • Norman, K., N. Stobaus, M. Pirlich, and A. Bosy-Westphal 2012. Bioelectrical phase angle and impedance vector analysis—clinical relevance and applicability of impedance parameters. Clin Nutr 31:854–861.
  • Okorodudu, D. O., M. F. Jumean, V. M. Montori, A. Romero-Corral, V. K. Somers, P. J. Erwin, and F. Lopez-Jimenez 2010. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) 34:791–799.
  • Paiva, S. I., L. R. Borges, D. Halpern-Silveira, M. C. Assunção, A. J. Barros, and M. C. Gonzalez 2010. Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 19:187–192.
  • Pape, U. F., U. Berndt, J. Müller-Nordhorn, M. Böhmig, S. Roll, M. Koch, S. N. Willich, and B. Wiedenmann 2008. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 15:1083–1097. doi:10.1677/ERC-08-0017.
  • Plöckinger, U., G. Rindi, R. Arnold, B. Eriksson, E. P. Krenning, W. W. de Herder, A. Goede, M. Caplin, K. Oberg, J. C. Reubi, O. Nilsson, G. Delle Fave, P. Ruszniewski, H. Ahlman, and B. Wiedenmann, European Neuroendocrine Tumour Society. 2004. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80:394–424.
  • Prado, C. M., J. R. Lieffers, L. J. McCargar, T. Reiman, M. B. Sawyer, L. Martin, and V. E. Baracos 2008. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635.
  • Qadir, M. I., and S. A. Malik 2008. Plasma lipid profile in gynecologic cancers. Eur J Gynaecol Oncol 29:158–161.
  • Rambaud, J. C., R. Jian, B. Flourie, M. Hautefeuille, M. Salmeron, F. Thuillier, A. Ruskone, C. Florent, F. Chaoui, and J. J. Bernier 1988. Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time. Gut 29:537–543.
  • Ray, G., and S. A. Husain 2001. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34:71–76.
  • Resmini, E., F. Minuto, A. Colao, and D. Ferone 2009. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol 46:85–95. doi: 10.1007/s00592-009-0112-9.
  • Rindi, G., and B. Wiedenmann 2011. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 8:54–64. doi:10.1038/nrendo.2011.120.
  • Rock, C. L., C. Doyle, W. Demark-Wahnefried, J. Meyerhardt, K. S. Courneya, A. L. Schwartz, E. V. Bandera, K. K. Hamilton, B. Grant, M. McCullough, T. Byers, and T. Gansler 2012. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243–274.
  • NHS Foundation Trust 2014. Foods and Neuroendocrine Tumours (NETs). Dietary tips in NETs. http://s3-eu-west-1.amazonaws.com/files.royalfree.nhs.uk/Patient_resources/NETs/Food_and_NETs.pdf (Accessed 09 Aug 2017).
  • Shah, G. M., R. G. Shah, H. Veillette, J. B. Kirkland, J. L. Pasieka, and R. R. Warner 2005. Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am J Gastroenterol 100:2307Y2314.
  • Sharma, M., J. Tuaine, B. McLaren, D. L. Waters, K. Black, L. M. Jones, and S. P. McCormick 2016. Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells. PLoS One 11:e0148049. doi: 10.1371/journal.pone.0148049.
  • Sofi, F., C. Macchi, R. Abbate, G. F. Gensini, and A. Casini 2014. Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr 17:2769–2782.
  • Schiller, L. R., D. S. Pardi, and J. H. Sellin 2017. Chronic Diarrhoea: Diagnosis and Management. Clin Gastroenterol Hepatol 15:182–193. e3. doi: 10.1016/j.cgh.2016.07.028.
  • Schlumberger, M., L. Bastholt, H. Dralle, B. Jarzab, F. Pacini, and J. W. A. Smit 2012. European thyroid association guidelines for metastatic medullary thyroid cancer. Eur Thyroid J 1:5–14. doi.org/10.1159/000336977.
  • Schwingshackl, L., and G. Hoffmann 2014. Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer 135:1884–1897.
  • Shin, J. J., P. Gorden, and S. K. Libutti 2010. Insulinoma: pathophysiology, localization and management. Future Oncol 6:229–237. doi: 10.2217/fon.09.165.
  • Stein, A., W. Voigt, and K. Jordan 2010. Chemotherapy-induced diarrhoea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2:51–63. doi: 10.1177/1758834009355164.
  • Thosani, S., M. Ayala-Ramirez, A. Román-González, S. Zhou, N. Thosani, A. Bisanz, and C. Jimenez 2015. Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma. Eur J Endocrinol 173:377–387. doi: 10.1530/EJE-15-0456.
  • Utsumi, T., N. Kobayashi, and H. Hanada 2007. Recent perspectives of endocrine therapy for breast cancer. Breast Cancer 14:194–199.
  • Vítko, S., R. Margreiter, W. Weimar, J. Dantal, H. G. Viljoen, Y. Li, A. Jappe, and N. Cretin, RAD B201 Study Group 2004. Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients. Transplantation 78:1532–1540.
  • Warner, M. 2009. Nutritional concerns for the carcinoid patient: developing nutrition guidelines for persons with carcinoid disease. Carcinoid Cancer Foundation Web site http://carcinoid.org/pcf/lectures/docs/MwarnerlectureSept2.htm (Accessed 09 Aug 2017).
  • Yao, J. C., M. Hassan, A. Phan, C. Dagohoy, C. Leary, J. E. Mares, E. K. Abdalla, J. B. Fleming, J. N. Vauthey, A. Rashid, and D. B. Evans 2008. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States. J Clin Oncol 26:3063–72. doi:10.1200/JCO.2007.15.4377.
  • Zhang, H. H., J. Huang, K. Düvel, B. Boback, S. Wu, R. M. Squillace, C. L. Wu, and B. D. Manning 2009. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 4:e6189.
  • Zhang, W. D., D. R. Liu, P. Wang, J. G. Zhao, Z. F. Wang, and L. I. Chen 2016. Clinical treatment of gastrinoma: A case report and review of the literature. Oncol Lett 11:3433–3437.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.